aTyr Pharma, Inc. (ATYR) Balance Sheet
As of 2026-06-30 (10-Q), aTyr Pharma, Inc. (ATYR) reported total assets of $69.8M and shareholders' equity of $48.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $16.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ATYRaTyr Pharma, Inc.Follow ATYR — free
—
Price chart with a free account
- Market cap
- 16.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 53.0 | 38.4 | 21.1 | 23.0 | 9.2 | 17.0 | 2.3 | 10.0 | 22.5 | 11.1 | 10.7 | 16.2 | |
| Short-term investments | 42.5 | 33.8 | 64.0 | 26.6 | 21.9 | 14.7 | 105.6 | 56.2 | 75.6 | 61.1 | 67.9 | 41.3 | |
| Current assets | 98.0 | 74.8 | 87.0 | 50.8 | 31.9 | 35.5 | 113.6 | 80.9 | 103.0 | 82.0 | 80.2 | 58.4 | |
| Total assets | 129.7 | 80.5 | 89.4 | 52.7 | 36.2 | 38.7 | 115.5 | 95.8 | 120.7 | 96.8 | 93.0 | 69.8 | |
| Current liabilities | 12.1 | 8.5 | 10.4 | 10.8 | 12.9 | 5.9 | 6.0 | 13.9 | 16.4 | 15.0 | 15.1 | 11.4 | |
| Long-term debt | 1.8 | 9.2 | 14.7 | 8.3 | — | — | — | — | — | — | — | — | |
| Short-term debt | 3.4 | 0.3 | 5.0 | 7.8 | 8.7 | — | — | — | — | — | — | — | |
| Shareholders' equity | 115.1 | 62.8 | 64.2 | 33.7 | 21.2 | 31.7 | 109.3 | 71.5 | 90.7 | 70.0 | 67.5 | 48.8 |
USD millions · SEC XBRL
aTyr Pharma, Inc. — questions
- How much cash does aTyr Pharma, Inc. have?
- $16.2M in cash and cash equivalents as of 2026-06-30.
- What are aTyr Pharma, Inc.'s total assets?
- $69.8M as of 2026-06-30.
- What is aTyr Pharma, Inc.'s shareholders' equity?
- $48.8M as of 2026-06-30.
Every figure on this page comes from aTyr Pharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.